IL6 and autoimmune disease: Substantial increases in soluble circulating native CRP occur, following immune cell-mediated liver stimulation by interleukin-6 (IL-6), in individuals with infection and tissue damage, and may result from an acute insult such as sepsis, myocardial infarction or stroke or from chronic conditions (with prolonged elevation) including a variety of autoimmune diseases (2).